These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 9862761)

  • 1. Treatment with liposome-bound recombinant human tumor necrosis factor-alpha suppresses parasitemia and protects against Plasmodium berghei k173-induced experimental cerebral malaria in mice.
    Postma NS; Crommelin DJ; Eling WM; Zuidema J
    J Pharmacol Exp Ther; 1999 Jan; 288(1):114-20. PubMed ID: 9862761
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment with recombinant human tumour necrosis factor-alpha reduces parasitaemia and prevents Plasmodium berghei K173-induced experimental cerebral malaria in mice.
    Postma NS; Hermsen CC; Crommelin DJ; Zuidema J; Eling WM
    Parasitology; 1999 Jan; 118 ( Pt 1)():7-15. PubMed ID: 10070656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thiolated recombinant human tumor necrosis factor-alpha protects against Plasmodium berghei K173-induced experimental cerebral malaria in mice.
    Postma NS; Hermsen RC; Crommelin DJ; Eling WM; Zuidema J
    Antimicrob Agents Chemother; 1999 May; 43(5):1027-33. PubMed ID: 10223910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies of effects of recombinant human tumor necrosis factor on autochthonous tumor and transplanted normal tissue in mice.
    McIntosh JK; Mulé JJ; Travis WD; Rosenberg SA
    Cancer Res; 1990 Apr; 50(8):2463-9. PubMed ID: 2317830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination cytokine immunotherapy with tumor necrosis factor alpha, interleukin 2, and alpha-interferon and its synergistic antitumor effects in mice.
    McIntosh JK; Mulé JJ; Krosnick JA; Rosenberg SA
    Cancer Res; 1989 Mar; 49(6):1408-14. PubMed ID: 2784349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic antitumor effects of immunotherapy with recombinant interleukin-2 and recombinant tumor necrosis factor-alpha.
    McIntosh JK; Mulé JJ; Merino MJ; Rosenberg SA
    Cancer Res; 1988 Jul; 48(14):4011-7. PubMed ID: 3260130
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of antitumor efficacy by the combination of recombinant tumor necrosis factor and chemotherapeutic agents in vivo.
    Krosnick JA; Mulé JJ; McIntosh JK; Rosenberg SA
    Cancer Res; 1989 Jul; 49(14):3729-33. PubMed ID: 2736513
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of IFN-gamma receptor-medicated signaling in pathology and anti-malarial immunity induced by Plasmodium berghei infection.
    Amani V; Vigário AM; Belnoue E; Marussig M; Fonseca L; Mazier D; Rénia L
    Eur J Immunol; 2000 Jun; 30(6):1646-55. PubMed ID: 10898501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmodium vinckei: optimization of desferrioxamine B delivery in the treatment of murine malaria.
    Postma NS; Hermsen CC; Zuidema J; Eling WM
    Exp Parasitol; 1998 Jul; 89(3):323-30. PubMed ID: 9676710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antimalarial effect of agmatine on Plasmodium berghei K173 strain.
    Su RB; Wei XL; Liu Y; Li J
    Acta Pharmacol Sin; 2003 Sep; 24(9):918-22. PubMed ID: 12956942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the anti-tumor efficacy of systemically administered recombinant tumor necrosis factor against several murine tumors in vivo.
    Asher A; Mulé JJ; Reichert CM; Shiloni E; Rosenberg SA
    J Immunol; 1987 Feb; 138(3):963-74. PubMed ID: 3805720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concurrent infection with Heligmosomoides polygyrus modulates murine host response against Plasmodium berghei ANKA infection.
    Tetsutani K; Ishiwata K; Torii M; Hamano S; Hisaeda H; Himeno K
    Am J Trop Med Hyg; 2008 Dec; 79(6):819-22. PubMed ID: 19052285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Manipulation of oxygen radical-scavenging capacity in mice alters host sensitivity to tumor necrosis factor toxicity but does not interfere with its antitumor efficacy.
    Hauser GJ; McIntosh JK; Travis WD; Rosenberg SA
    Cancer Res; 1990 Jun; 50(12):3503-8. PubMed ID: 2340500
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of innate immunological factors by STEALTH liposome-encapsulated tumor necrosis factor-alpha in a colon tumor xenograft model.
    Kim DW; Andres ML; Kajioka EH; Dutta-Roy R; Miller GM; Seynhaeve AL; ten Hagen TL; Gridley DS
    Anticancer Res; 2002; 22(2A):777-88. PubMed ID: 12014650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-10 plays a crucial role for the protection of experimental cerebral malaria by co-infection with non-lethal malaria parasites.
    Niikura M; Kamiya S; Nakane A; Kita K; Kobayashi F
    Int J Parasitol; 2010 Jan; 40(1):101-8. PubMed ID: 19735663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA; Ruenruetai U; Noor Rain A; Khozirah S; Zakiah I
    Trop Biomed; 2006 Dec; 23(2):140-6. PubMed ID: 17322815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estradiol, but not dehydroepiandrosterone, decreases parasitemia and increases the incidence of cerebral malaria and the mortality in plasmodium berghei ANKA-infected CBA mice.
    Libonati RM; Cunha MG; Souza JM; Santos MV; Oliveira SG; Daniel-Ribeiro CT; Carvalho LJ; do Nascimento JL
    Neuroimmunomodulation; 2006; 13(1):28-35. PubMed ID: 16699290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different responses of three rodent Plasmodia species, Plasmodium yoelii 17XL, P. berghei NK65 and P. chabaudi AS on treatment with febrifugine and isofebrifugine mixture from Hydrangea macrophylla var. Otaksa leaf in ICR mice.
    Ishih A; Miyase T; Ohori K; Terada M
    Phytother Res; 2003 Jun; 17(6):650-6. PubMed ID: 12820234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunomodulatory and toxic effects of free and liposome-encapsulated tumor necrosis factor alpha in rats.
    Debs RJ; Fuchs HJ; Philip R; Brunette EN; Düzgüneş N; Shellito JE; Liggitt D; Patton JR
    Cancer Res; 1990 Jan; 50(2):375-80. PubMed ID: 2295077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human erythropoietin prevents the death of mice during cerebral malaria.
    Kaiser K; Texier A; Ferrandiz J; Buguet A; Meiller A; Latour C; Peyron F; Cespuglio R; Picot S
    J Infect Dis; 2006 Apr; 193(7):987-95. PubMed ID: 16518761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.